35th week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190262351 | NORIBOGAINE COMPOSITIONS | 2019-08-29 |
20190262352 | ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS | 2019-08-29 |
20190262353 | TREATMENT FOR PROGRESSIVE MULTIPLE SCLEROSIS | 2019-08-29 |
20190262354 | COMBINATIONS OF PBD-BASED ANTIBODY DRUG CONJUGATES WITH FLT3 INHIBITORS | 2019-08-29 |
20190262355 | COMBINATION OF A BRD4 INHIBITOR AND AN ANTIFOLATE FOR THE THERAPY OF CANCER | 2019-08-29 |
20190262356 | HETEROCYCLIC AMIDES AS KINASE INHIBITORS | 2019-08-29 |
20190262357 | PREVENTATIVE OR THERAPEUTIC AGENT FOR PULMONARY HYPERTENSION INCLUDING CRUDE DRUG COMPONENT | 2019-08-29 |
20190262358 | NEURO-PROTECTIVE AGENTS AND USES THEREOF | 2019-08-29 |
20190262360 | ANORDRIN COMPOSITIONS AND METHODS FOR TREATING DISEASES | 2019-08-29 |
20190262361 | Progesterone Receptor Modulators for Use in the Therapy of Uterine Fibroids | 2019-08-29 |
20190262362 | AMIDE DERIVATIVES OF SQUALAMINE FOR THE TREATMENT OF INFECTIONS | 2019-08-29 |
20190262363 | ANTAGONIST OF MINERALOCORTICOID RECEPTOR FOR THE TREATMENT OF OSTEOARTHRITIS | 2019-08-29 |
20190262364 | SELECTIVE HIGH-AFFINITY POLYDENTATE LIGANDS AND METHODS OF MAKING SUCH | 2019-08-29 |
20190262365 | ANTIVIRAL ARYL-AMIDE PHOSPHODIAMIDE COMPOUNDS | 2019-08-29 |
20190262366 | ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF | 2019-08-29 |
20190262367 | ORAL FORMULATIONS MIMETIC OF ROUX-EN-Y GASTRIC BYPASS ACTIONS ON THE ILEAL BRAKE; COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS AND SYSTEMS FOR TREATMENT OF METABOLIC SYNDROME MANIFESTATIONS INCLUDING INSULIN RESISTANCE, FATTY LIVER DISEASE, HYPERLIPIDEMIA, AND TYPE 2 DIABETES | 2019-08-29 |
20190262368 | BINDING PROTEINS SPECIFIC FOR LOX1 AND USES THEREOF | 2019-08-29 |
20190262369 | OPRT Expression And Cancer Treatment Outcome | 2019-08-29 |
20190262370 | CD99 Inhibitors and Their Uses | 2019-08-29 |
20190262371 | METHODS AND COMPOSITION FOR THE TREATMENT OF RNA VIRAL INFECTIONS | 2019-08-29 |
20190262372 | COMPOUNDS,COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | 2019-08-29 |
20190262373 | METHODS AND COMPOSITIONS FOR TARGETED GENE TRANSFER | 2019-08-29 |
20190262374 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE | 2019-08-29 |
20190262375 | EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY | 2019-08-29 |
20190262376 | COMPOSITIONS COMPRISING ANTISENSE-ENCODED ERYTHROPOIETIN RECEPTOR AND USE THEREOF | 2019-08-29 |
20190262377 | METHODS AND COMPOSITIONS FOR MODULATING CANCER STEM CELLS | 2019-08-29 |
20190262378 | DOUBLE-STRANDED NUCLEIC ACID MOLECULE AND USE THEREOF | 2019-08-29 |
20190262379 | TREATMENTS OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) | 2019-08-29 |
20190262380 | BIOCOMPATIBLE PERITONEAL DIALYSATE | 2019-08-29 |
20190262381 | ANIMAL FEED COMPOSITIONS AND METHODS OF USING THE SAME | 2019-08-29 |
20190262382 | Treatment of Colitis with Resistant Starch | 2019-08-29 |
20190262383 | CCR7 APTAMERS AND USES THEREOF | 2019-08-29 |
20190262384 | TGF-BETA OLIGONUCLEOTIDE FOR USE IN TREATMENT OF OPHTHALMIC DISEASES | 2019-08-29 |
20190262385 | METHOD OF USING CYCLODEXTRIN | 2019-08-29 |
20190262386 | Sulfated Glycosaminoglycan Biomaterials as Proteoglycan Mimics | 2019-08-29 |
20190262387 | BIOMATERIALS COMPRISING HYALURONIC ACID BINDING PEPTIDES AND EXTRACELLULAR MATRIX BINDING PEPTIDES FOR HYALURONIC ACID RETENTION AND TISSUE ENGINEERING APPLICATIONS | 2019-08-29 |
20190262388 | LIQUID COMPOSITION FOR USE IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX | 2019-08-29 |
20190262389 | DERMAL PROTECTOR | 2019-08-29 |
20190262390 | TOPICAL AND ORAL FORMULATIONS COMPRISING TAURINE AND MAGNESIUM FOR THE TREATMENT OF ROSACEA | 2019-08-29 |
20190262391 | AMORPHOUS CALCIUM CARBONATE FOR TREATING A LEUKEMIA | 2019-08-29 |
20190262392 | Effervescent Dosage Form | 2019-08-29 |
20190262393 | HYDROLYZED TETRAVALENT METAL SALTS AND METHODS OF BIOFILM INHIBITION | 2019-08-29 |
20190262394 | FLOWABLE TISSUE MATRICES | 2019-08-29 |
20190262395 | METHOD OF TREATING CANCER | 2019-08-29 |
20190262396 | PREVENTION OF GRAFT REJECTION BY PRIOR USE OF MODIFIED GRAFTS | 2019-08-29 |
20190262397 | CHIMERIC ANTIGEN RECEPTOR | 2019-08-29 |
20190262398 | TIM3 HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE | 2019-08-29 |
20190262399 | COMPOSITIONS AND METHODS FOR EVALUATING AND MODULATING IMMUNE RESPONSES | 2019-08-29 |
20190262400 | ARTIFICIAL ANTIGEN PRESENTING CELLS FOR EXPANDING IMMUNE CELLS FOR IMMUNOTHERAPY | 2019-08-29 |
20190262401 | COMPOSITIONS FOR RESTORING GENE EXPRESSION IN NEUROPSYCHIATRIC OR NEURODEGENERATIVE DISORDERS | 2019-08-29 |
20190262402 | CULTURED THYMUS TISSUE TRANSPLANTATION PROMOTES DONOR-SPECIFIC TOLERANCE TO ALLOGENEIC SOLID ORGAN TRANSPLANTS | 2019-08-29 |
20190262403 | METHODS, APPARATUSES AND SYSTEMS FOR INSTILLING STEM CELLS AND PHARMACEUTICALS INTO THE HUMAN VENTRICULAR SYSTEM | 2019-08-29 |
20190262404 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING IMMUNE DISEASE OR INFLAMMATORY DISEASE INCLUDING INFLAMMATORY STIMULATED MESENCHYMAL STEM CELL | 2019-08-29 |
20190262405 | PLURIPOTENT STEM CELL-DERIVED OLIGODENDROCYTE PROGENITOR CELLS FOR THE TREATMENT OF SPINAL CORD INJURY | 2019-08-29 |
20190262406 | METHODS AND COMPOSITIONS FOR TREATMENT OF BONE DEFECTS WITH PLACENTAL CELL POPULATIONS | 2019-08-29 |
20190262407 | PROBIOTIC COMPOSITIONS AND METHODS OF USE THEREOF | 2019-08-29 |
20190262408 | AGENT ACTING ON TRANSCELLULAR ION TRANSPORTER IN INTESTINAL TRACT, AGENT FOR ACTIVATING CHLORIDE CHANNEL, AGENT FOR PREVENTING OR TREATING RENAL DISEASE, OR AGENT FOR PROMOTING DEFECATION | 2019-08-29 |
20190262409 | NOVEL LACTOBACILLUS SAKEI AND COMPOSITION COMPRISING THE SAME | 2019-08-29 |
20190262410 | ONCOLYTIC HSV VECTOR | 2019-08-29 |
20190262411 | FEED SUPPLEMENT | 2019-08-29 |
20190262412 | COMPOSITION FOR PREVENTING OR TREATING OBESITY CONTAINING ETHANOLIC EXTRACT OF RAMULUS MORI | 2019-08-29 |
20190262413 | COMPOSITION OF COMBINED PLANT PROTEINS FOR TREATMENT OF CANCER AND DIABETES | 2019-08-29 |
20190262414 | NATURAL FORMULATION FOR TREATING HANGOVER | 2019-08-29 |
20190262415 | Supplement for inducing and sustaining nutritional ketosis | 2019-08-29 |
20190262416 | NUTRITIONAL SUPPLEMENT FOR MAMMALS | 2019-08-29 |
20190262417 | ANTIBODY DRUG CONJUGATE (ADC) PURIFICATION | 2019-08-29 |
20190262418 | COMPOSITIONS AND METHODS FOR INVASIVE AND NON-INVASIVE PROCEDURAL SKINCARE | 2019-08-29 |
20190262419 | FORMULATIONS CONTAINING A SOMATOSTATIN RECEPTOR AGONIST | 2019-08-29 |
20190262420 | COMPOSITIONS USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | 2019-08-29 |
20190262421 | MODULATORS OF SYNDECAN-2 AND USES THEREOF | 2019-08-29 |
20190262422 | HYPOXIA-INDUCED MITOGENIC FACTOR | 2019-08-29 |
20190262423 | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DISORDERS | 2019-08-29 |
20190262424 | IMMUNOSUPPRESSIVE COMPOSITION FOR USE IN TREATING IMMUNOLOGICAL DISORDERS | 2019-08-29 |
20190262425 | USES OF IL-41 | 2019-08-29 |
20190262426 | Hydrogel-Linked IL-1ra Prodrug | 2019-08-29 |
20190262427 | TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY | 2019-08-29 |
20190262428 | TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY | 2019-08-29 |
20190262429 | FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF | 2019-08-29 |
20190262430 | USE OF COLLAGEN HYDROLYSATE FOR IMPROVING ENDURANCE PERFORMANCE AND FOR STIMULATING LIPID CATABOLISM | 2019-08-29 |
20190262431 | CBL-FAMILY INHIBITOR COMPRISING A CBL-FAMILY TKB DOMAIN BINDING PEPTIDE FOR THE PREVENTION OR TREATMENT OF DISEASES | 2019-08-29 |
20190262432 | TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS | 2019-08-29 |
20190262433 | ANTIMICROBIAL COMPOSITIONS AND METHODS EMPLOYING SAME | 2019-08-29 |
20190262434 | IMMUNOGLOBULIN PROTEASES, COMPOSITIONS, AND USES THEREOF | 2019-08-29 |
20190262435 | PROENZYME COMPOSITION | 2019-08-29 |
20190262436 | METHOD FOR PRODUCING PEPTIDE ACE INHIBITORS | 2019-08-29 |
20190262437 | USE OF THERMOLYSIN TO REDUCE OR ELIMINATE BACTERIAL BIOFILMS FROM SURFACES | 2019-08-29 |
20190262438 | Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease | 2019-08-29 |
20190262439 | PLANTAR HEEL PAIN SYNDROME (PLANTAR FASCIITIS) TREATMENT | 2019-08-29 |
20190262440 | COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDERS | 2019-08-29 |
20190262441 | Peptide Conjugated Particles | 2019-08-29 |
20190262442 | METHODS AND COMPOSITIONS RELATED TO Th-1 DENDRITIC CELLS | 2019-08-29 |
20190262443 | Therapeutic Cancer Vaccine | 2019-08-29 |
20190262444 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS | 2019-08-29 |
20190262445 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS | 2019-08-29 |
20190262446 | Compositions and Methods for Increasing Immunogenicity of Glycoprotein Vaccines | 2019-08-29 |
20190262447 | Vaccine | 2019-08-29 |
20190262448 | Cationic Oil-In-Water Emulsions | 2019-08-29 |
20190262449 | METHODS FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND INFLAMMATION | 2019-08-29 |
20190262450 | LIQUID PHARMACEUTICAL COMPOSITION | 2019-08-29 |
20190262451 | RADIOTHERAPY IMPROVEMENTS | 2019-08-29 |